🇺🇸 FDA
Patent

US 7745468

Compounds for treatment of cell proliferative diseases

granted A61KA61K31/277A61K45/06

Quick answer

US patent 7745468 (Compounds for treatment of cell proliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/277, A61K45/06, A61P, A61P1/00